Diabetic Retinopathy: Evidence-Based Management
Screening for diabetic retinopathy
Publication
, Chapter
Browning, DJ
January 1, 2010
Screening is worthwhile when certain criteria are met: a disease has public health importance; an effective treatment exists; an interval exists within which treatment can effect benefit; and the disease is neither too rare nor too common.1 Screening for diabetes mellitus in those over 40 years of age and screening for diabetic retinopathy (DR) in those with known diabetes mellitus fulfill these criteria.2,3 Beyond improving health-related outcomes, treatment of diabetes and DR is cost effective.4,5,6 Thus, the value of screening for DR is widely recognized. There is, however, controversy regarding the best screening method and screening intervals. 7 © 2010 Springer-Verlag New York.
Duke Scholars
DOI
ISBN
9780387858999
Publication Date
January 1, 2010
Start / End Page
369 / 385
Citation
APA
Chicago
ICMJE
MLA
NLM
Browning, D. J. (2010). Screening for diabetic retinopathy. In Diabetic Retinopathy: Evidence-Based Management (pp. 369–385). https://doi.org/10.1007/978-0-387-85900-2_14
Browning, D. J. “Screening for diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 369–85, 2010. https://doi.org/10.1007/978-0-387-85900-2_14.
Browning DJ. Screening for diabetic retinopathy. In: Diabetic Retinopathy: Evidence-Based Management. 2010. p. 369–85.
Browning, D. J. “Screening for diabetic retinopathy.” Diabetic Retinopathy: Evidence-Based Management, 2010, pp. 369–85. Scopus, doi:10.1007/978-0-387-85900-2_14.
Browning DJ. Screening for diabetic retinopathy. Diabetic Retinopathy: Evidence-Based Management. 2010. p. 369–385.
DOI
ISBN
9780387858999
Publication Date
January 1, 2010
Start / End Page
369 / 385